Pharmaceutical composition for the treatment or prevention of a malignant tumor
US6203795A · kind A · utility
1Cited by
0References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 1998 |
| Grant date | Mar 20, 2001 |
| Priority date | — |
| Expiry date | May 22, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application provides a polypeptide and a pharmaceutical composition which comprises said polypeptide, wherein said polypeptide is recognized by a particular antibody H23, which recognizes a particular tumor antigen expressed on breast cancer cells. This antibody specifically binds to an epitope comprising a tandem repeat sequence of 20 amino acids comprised in a transmembrane form as well as a secreted form of the polypeptides specifically bound by antibody H23.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.